Great question, and one that many people going through lymphoma treatment wonder about. The short answer is: often yes, but it varies from person to person.
Chemotherapy-induced peripheral neuropathy (CIPN) affects around 30% to 40% of people who undergo cancer treatment. The good news is that for many people, symptoms Show Full Answer
Great question, and one that many people going through lymphoma treatment wonder about. The short answer is: often yes, but it varies from person to person.
Chemotherapy-induced peripheral neuropathy (CIPN) affects around 30% to 40% of people who undergo cancer treatment. The good news is that for many people, symptoms like numbness, tingling, and pain do subside or resolve after treatment ends. As one MyLymphomaTeam member shared, "I had numbness in my hands and feet, but it went away. The numbness is common and will likely get better after treatment stops."
However, for some people, neuropathy symptoms can linger well beyond the end of treatment. Some MyLymphomaTeam members have reported ongoing bone and nerve pain years after finishing chemotherapy, with one noting they still experienced it four years into remission. Here are some key things to keep in mind:
- Certain chemo drugs are more likely to cause lasting neuropathy, including Vincristine (Oncovin), Brentuximab vedotin (Adcetris), and platinum-based drugs
- Symptoms can sometimes worsen before they improve
- Always let your doctor know if neuropathy develops or gets worse so they can help manage it
It's really important to keep your care team in the loop — they can explore treatment options to help manage the symptoms while your nerves heal.
May 8
Join
Your Privacy Choices
